Samsung Biologics Co. Ltd.
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development 2024-10-14 19:00
Samsung Biologics launches development platforms for enhanced therapeutic efficacy 2024-09-25 19:00
Samsung Biologics obtains three global ISO certifications 2022-10-13 19:00
'Sustainable CDMO' Samsung Biologics releases 2022 ESG Report 2022-07-11 19:00
Samsung Biologics holds 11th Annual General Meeting of Shareholders 2022-03-29 09:42
Samsung Biologics receives 2022 CMO Leadership Award in all six categories 2022-02-07 20:00
Moderna COVID-19 Vaccine Manufactured in Korea by Samsung Biologics Receives Marketing Authorization from Ministry of Food and Drug Safety of Korea 2021-12-14 13:34
Samsung Biologics and AstraZeneca expand strategic manufacturing partnership to include COVID-19 and cancer therapy 2021-12-14 08:55
Samsung Biologics adds to global ISO certifications with Quality Management System 2021-12-07 13:04
GreenLight Biosciences and Samsung Biologics announce collaboration to build capacity for messenger RNA Vaccine Manufacturing 2021-11-24 20:00
Samsung Biologics Reports Third Quarter 2021 Financial Results 2021-10-26 15:23
Samsung Biologics showcases its newest CDO process platform, S-Cellerate™, at BPI 2021, offering expedited timeline to IND and BLA 2021-09-22 18:00
Samsung Biologics Joins Frontier 1.5D Project as part of 2050 Carbon Neutral Initiative 2021-09-13 12:41
Kineta and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-VISTA Antibody Immunotherapy 2021-07-20 20:00
Samsung Biologics Issues Its First Annual Sustainability Report 2021-06-25 09:01
Over a year into the global pandemic, Samsung Biologics continues to leverage innovative virtual platform for remote audits and regulatory inspections 2021-06-23 19:28
Samsung Biologics and KAHR Medical Announce Development and Manufacturing Agreement for Cancer Immunotherapy Drug Candidate 2021-06-02 19:00
Samsung Biologics to add mRNA vaccine drug substance manufacturing suite to expand portfolio of services 2021-05-31 19:00
Samsung Biologics Adds Four Global ISO Certifications For BCMS, Energy, Health & Safety, and Environmental Management 2021-05-28 20:00
Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna's COVID-19 Vaccine 2021-05-23 00:00
1 2